U.S. Lateral Flow Assay Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Lateral Flow Readers), By Application (Veterinary Diagnostics, Food Safety & Environment Testing), By Technique, By End use, And Segment Forecasts, 2025 - 203

U.S. Lateral Flow Assay Market Trends

The U.S. lateral flow assay market size was valued at USD 2.82 billion in 2024 and is projected to reach USD 4.63 billion by 2033, growing at a CAGR of 6.08% from 2025 to 2033. The rising prevalence of infectious diseases places immense pressure on public health systems worldwide. With increasing urbanization, interconnectivity, antimicrobial resistance, and the rising impact of climate change, experts stress the urgent need for enhanced infectious disease surveillance, prevention, and diagnostic capabilities. The global rise in infectious diseases significantly drives the lateral flow assays (LFA) market by necessitating rapid diagnostic solutions. According to the Centers for Disease Control and Prevention (CDC), tuberculosis (TB) cases in the U.S. increased from 7,874 in 2022 to 10,347 in 2024, reflecting a notable public health challenge.

The mosquito-borne disease testing segment is projected to experience significant growth due to the rising prevalence of mosquito-borne infections, including West Nile virus (WNV), dengue, chikungunya, Zika virus, malaria, and yellow fever. The increasing incidence of these diseases has heightened the demand for rapid and efficient diagnostic solutions, particularly in regions prone to outbreaks. According to the Centers for Disease Control and Prevention (CDC), West Nile virus (WNV) has become endemic in the U.S., with cases reported in all 48 contiguous states and the District of Columbia, predominantly during the summer and fall months. As of November 2024, the CDC recorded 1,466 cases of WNV, while in 2022, 913 human cases were reported, with 70% classified as neuroinvasive and 30% as non-neuroinvasive. The increasing burden of mosquito-borne diseases, alongside ongoing health crises such as COVID-19 and monkeypox, underscores the urgent need for effective diagnostic and surveillance measures.

Public health initiatives also play a crucial role in market expansion. The CDC’s Influenza Division International Program focuses on surveillance, pandemic preparedness, research, and vaccination programs to combat influenza. Additionally, the National Association of County and City Health Officials supports local health departments in influenza prevention and control.

U.S. Lateral Flow Assay Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. lateral flow assay market report based on product, application, technique, and end use:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Kits & Reagents
• Lateral Flow Readers
• Benchtop Readers
• Digital Readers
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Clinical Testing
• Infectious Disease Testing
• COVID-19
• Mosquito Borne Disease Testing
• Malaria Testing
• Dengue Testing
• Zika Testing
• Chikungunya Testing
• Others
• Influenza Testing
• Sexually Transmitted Infection Testing
• HIV Testing
• HPV Testing
• Chlamydia Testing
• Gonorrhea Testing
• Syphilis Testing
• Other STI Testing
• Hepatitis
• Tuberculosis
• Other Infectious Diseases
• Cardiac Marker Testing
• Troponin I and T Testing
• CK-MB Testing
• BNP and NT-Probnp Testing
• Myoglobin Testing
• D-Dimer Testing
• Other Cardiac Marker Tests
• Pregnancy & Fertility Testing
• Pregnancy Testing
• Fertility Testing
• Cholesterol Testing/Lipid Profile
• Drugs of Abuse Testing
• Other Clinical Tests
• Veterinary Diagnostics
• Food Safety & Environment Testing
• Drug Development & Quality Testing
• Technique Outlook (Revenue, USD Million, 2021 - 2033)
• Sandwich Assays
• Competitive Assays
• Multiplex Detection Assays
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals & Clinics
• Diagnostic Laboratories
• Home Care
• Pharmaceutical & Biotechnology Companies
• Others